Breaks Categories: News

MondayJun 22, 2020 10:20 am

CannabisNewsBreaks – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) Announces Expansion of Cultivation and Processing Capacity

VIVO Cannabis (TSX: VIVO) (OTCQX: VVCIF) today announced that its wholly-owned subsidiary, Canna Farms Limited, has received all necessary Health Canada approvals to commence operations in its Phase 5 expansion, and that its wholly-owned subsidiary, ABcann Medicinals Inc. ("NCC"), has begun commercial production in its ethanol extraction suite. According to the update, the Phase 5 expansion of the Hope, British Columbia facility consists of 10,000 square feet of production space customized to incorporate Canna Farms' two-tier growing systems, as well as vegetative, mother and processing rooms and storage vaults. "Health Canada's approval of Phase 5 is a major milestone for…

Continue Reading

FridayJun 19, 2020 12:17 pm

CannabisNewsBreaks – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) Partners with Medipharm Labs to Leverage GMP Production Capabilities, Accelerate Australian Market Presence

VIVO Cannabis (TSX: VIVO) (OTCQX: VVCIF) today announced that its subsidiary, Beacon Medical Australia Pty. Ltd. ("Beacon Medical Australia"), entered into an agreement with MediPharm Labs Australia Pty. Ltd. ("MediPharm Labs Australia"), a subsidiary of MediPharm Labs Corp. (TSX: LABS) ("MediPharm Labs"). Under the agreement, MediPharm Labs Australia will supply pharmaceutical-quality (GMP certified), formulated cannabis oil products to Beacon Medical Australia to sell into the Australian market. "VIVO's international efforts remain focused on the emerging Australian and German markets and we continue to seek out partnerships with organizations that have proven track records," Barry Fishman, CEO of VIVO, said in…

Continue Reading

FridayJun 19, 2020 10:20 am

CannabisNewsBreaks – Champignon Brands Inc.’s (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Dr. McIntyre / CRTCE Published in Two Peer Reviewed Study Journals

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, continues to highlight the scientific merit of its ketamine treatments for Major Depressive Disorder (“MDD”) while demonstrating rapid onset efficacy and safety of its treatment processes. To this accord, the Company today announced that its Chief Executive Officer, Dr. Roger McIntyre, and the Canadian Rapid Treatment Centre of Excellence (the “CRTCE”) have been recently published in two peer reviewed study journals (the “Peer Reviewed Studies”) focusing on ketamine’s safety, tolerability and effectiveness. “The publications of data as it relates…

Continue Reading

ThursdayJun 18, 2020 10:54 am

CannabisNewsBreaks – Youngevity International, Inc.’s (NASDAQ: YGYI) CLR Roasters Expands International Footprint Through Deal to Sell Espresso Brands into Panama

Youngevity International (NASDAQ: YGYI), a leading multi-channel lifestyle company operating in three distinct business segments including a commercial coffee enterprise and a commercial hemp production, today announced that its wholly-owned subsidiary CLR Roasters has signed a 5 year contract with H&H Coffee Group Export Corp.to sell CLR's espresso brands, Café La Rica and Café Cachita into Panama. Per the update, the terms are C.O.D. and F.O.B. Miami, with the initial order of approximately 60,000 units of Café Cachita Espresso bricks expected to ship this week, and a second order of the same amount of the brand Café La Rica planned…

Continue Reading

ThursdayJun 18, 2020 10:28 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Applies for NIH Grant to Support COVID-19 Therapy Studies, Receives Expanded Health Canada License

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, today announced its submission of a grant application to the U.S. National Institutes of Health (“NIH”) entitled "In vitro and in vivo animal exploratory pharmacokinetic and preliminary efficacy modelling of select orally administered antiviral compounds following DehydraTECH formulation enhancement." According to the update, the grant application is for funding to support Lexaria's second round of planned studies related to COVID-19 treatment possibilities. Additionally, the Company also reported that its subsidiary Lexaria CanPharm ULC has received a new license from Health Canada, issued in accordance with the…

Continue Reading

WednesdayJun 17, 2020 11:53 am

CannabisNewsBreaks – Cannabis Strategic Ventures, Inc. (NUGS) Issues LOI for Greenhouse Facility with Potential to More Than Double Production Capacity

Cannabis Strategic Ventures (OTCQB: NUGS), an emerging leader in the U.S. cannabis marketplace, today announced that it has issued a Letter of Intent (“LOI”) to obtain a new 300,000-square-foot greenhouse facility for cannabis cultivation. According to the update, negotiations are underway for the new facility that would more than double the Company’s cannabis production capacity. “In this environment, the market is going to take as much as we can produce given our steady evolution in product quality, and we see those conditions extending for quite some time,” Simon Yu, CEO of Cannabis Strategic Ventures, stated in the news release. “That…

Continue Reading

WednesdayJun 17, 2020 11:27 am

CannabisNewsBreaks – Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF) Announces Further Acceleration of Path to Commercialization, Expands Portfolio

Willow Biosciences (TSX: WLLW) (OTCQB: CANSF), a Canadian biotechnology company creating high purity, plant-derived compounds for the global pharmaceutical, health and wellness and consumer packaged goods industries, today announced further acceleration of its path to commercialization following continued scale-up development success and the addition of multiple new cannabinoids for production. "Willow's scientific and operational success to date has solidified the use of yeast fermentation as a production platform," Willow's CEO Trevor Peters stated in the news release. "Our scientific discoveries over the past 14 months have contributed to the development of not one, but five different cannabinoids and our pilot…

Continue Reading

TuesdayJun 16, 2020 12:01 pm

CannabisNewsBreaks – Sugarmade, Inc. (SGMD) Announces Record BudCars Sales Growth as It Gears Up to Open First LA Hub

Sugarmade (OTCQB: SGMD), together with its BudCars Cannabis Delivery Service (“BudCars”), today announced record growth in gross profits and gross profit margins for BudCars sales during the month of May (up 46% on a sequential month-over-month basis). Per the update, the Company continues to experience strong signals during the first half of June, with gross profits growing 9.9% on a week-over-week basis and believes this performance data provides a template for its per unit operational performance anticipated as it prepares for next month’s launch of its first Los Angeles hub. “As we gear up to open our first new hub…

Continue Reading

MondayJun 15, 2020 12:12 pm

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Expands Agreement with Stillwater Brands to Launch RIPPLE Suite of Products

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium, certified-organic cannabis, today announced the expansion of its exclusive licensing agreement with Colorado-based Stillwater Brands, under which it will be rolling out the powerful RIPPLE suite of products in Canada, including RIPPLE Gummies and RIPPLE QuickSticks. According to the update, TGOD leveraged Stillwater's proprietary technology to launch its first Cannabis 2.0 product at the end of March – TGOD Infuser 10mg THC – which quickly became one of the top selling SKUs within the beverage category across the country. Given the first product’s success, TGOD has…

Continue Reading

MondayJun 15, 2020 10:52 am

CannabisNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Announces Strategic Board Appointment of Canopy Growth CFO Mike Lee

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced appointment of Canopy Growth Corporation ("Canopy Growth") (TSX: WEED), (NYSE: CGC) Chief Financial Officer Mike Lee to its Board of Directors (the "Board"). According to the update, the Company expects that Lee's experience at Canopy Growth, Constellation Brands, Inc. and other leading consumer packaged goods and beverage companies will help strengthen its strategic execution as it continues to focus on developing a leading global cannabis portfolio. "Mike's addition to our Board is another sign of our strong and growing relationship with Canopy Growth and Constellation…

Continue Reading